New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease
October 8, 2019
Click here to read full article.
Gladstone team of (from left) Jae Kyu Ryu, Anke Meyer-Franke, Katerina Akassoglou, and Stephen Freedman worked with entrepreneur Edward Spack to launch MedaRed, Inc.